Literature DB >> 21905152

Spoilt for choice: implications of using alternative methods of costing hospital episode statistics.

Claudia Geue1, James Lewsey, Paula Lorgelly, Lindsay Govan, Carole Hart, Andrew Briggs.   

Abstract

In the absence of a 'gold standard' to estimate the economic burden of disease, a decision about the most appropriate costing method is required. Researchers have employed various methods to cost hospital stays, including per diem or diagnosis-related group (DRG)-based costs. Alternative methods differ in data collection and costing methodology. Using data from Scotland as an illustrative example, costing methods are compared, highlighting the wider implications for other countries with a publicly financed healthcare system. Five methods are compared using longitudinal data including baseline survey data (Midspan) linked to acute hospital admissions. Cost variables are derived using two forms of DRG-type costs, costs per diem, costs per episode-using a novel approach that distinguishes between variable and fixed costs and incorporates individual length of stay (LOS), and costs per episode using national average LOS. Cost estimates are generated using generalised linear model regression. Descriptive analysis shows substantial variation between costing methods. Differences found in regression analyses highlight the magnitude of variation in cost estimates for subgroups of the sample population. This paper emphasises that any inference made from econometric modelling of costs, where the marginal effect of explanatory variables is assessed, is substantially influenced by the costing method.
Copyright © 2011 John Wiley & Sons, Ltd.

Mesh:

Year:  2011        PMID: 21905152     DOI: 10.1002/hec.1785

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  21 in total

1.  Population ageing and healthcare expenditure projections: new evidence from a time to death approach.

Authors:  Claudia Geue; Andrew Briggs; James Lewsey; Paula Lorgelly
Journal:  Eur J Health Econ       Date:  2013-11-29

Review 2.  An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis.

Authors:  Matthew Franklin; James Lomas; Simon Walker; Tracey Young
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

3.  A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11.

Authors:  E Pizzo; A A Laverty; K J Phekoo; G AlJuburi; S A Green; D Bell; A Majeed
Journal:  J Public Health (Oxf)       Date:  2014-05-05       Impact factor: 2.341

4.  Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.

Authors:  Jane Daniels; Lee J Middleton; Versha Cheed; William McKinnon; Dikshyanta Rana; Fusun Sirkeci; Isaac Manyonda; Anna-Maria Belli; Mary Ann Lumsden; Jonathan Moss; Olivia Wu; Klim McPherson
Journal:  Health Technol Assess       Date:  2022-04       Impact factor: 4.106

5.  Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.

Authors:  Ciaran N Kohli-Lynch; James Lewsey; Kathleen A Boyd; Dustin D French; Neil Jordan; Andrew E Moran; Naveed Sattar; David Preiss; Andrew H Briggs
Journal:  Circulation       Date:  2022-03-07       Impact factor: 39.918

6.  Hospital expenditure at the end-of-life: what are the impacts of health status and health risks?

Authors:  Claudia Geue; Paula Lorgelly; James Lewsey; Carole Hart; Andrew Briggs
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

7.  Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.

Authors:  Conor L Mallucci; Michael D Jenkinson; Elizabeth J Conroy; John C Hartley; Michaela Brown; Tracy Moitt; Joanne Dalton; Tom Kearns; Michael J Griffiths; Giovanna Culeddu; Tom Solomon; Dyfrig Hughes; Carrol Gamble
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

8.  A general framework for classifying costing methods for economic evaluation of health care.

Authors:  Zuzana Špacírová; David Epstein; Leticia García-Mochón; Joan Rovira; Antonio Olry de Labry Lima; Jaime Espín
Journal:  Eur J Health Econ       Date:  2020-01-20

9.  Chronic disease multimorbidity transitions across healthcare interfaces and associated costs: a clinical-linkage database study.

Authors:  Umesh T Kadam; John Uttley; Peter W Jones; Zafar Iqbal
Journal:  BMJ Open       Date:  2013-07-19       Impact factor: 2.692

10.  Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).

Authors:  Joanna C Thorn; Emma L Turner; Luke Hounsome; Eleanor Walsh; Liz Down; Julia Verne; Jenny L Donovan; David E Neal; Freddie C Hamdy; Richard M Martin; Sian M Noble
Journal:  BMJ Open       Date:  2016-04-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.